Med. praxi. 2021;18(4):278-280 | DOI: 10.36290/med.2021.047
The treatment of arterial hypertension in patient with myocardial infaction in recent history, the percutaneous coronary intervention is just the beginning
- Centrum preventivní kardiologie, 3. interní klinika 1. LF UK a VFN, Praha
Increased activity of the sympathetic nervous system as well as increased activity of the renin-angiotensin-aldosterone system (RAAS) constitute the pathophysiological basis of the most common cardiac diseases - arterial hypertension, ischemic heart disease and chronic heart failure. According to this, beta-blockers and angiotensin-converting enzyme inhibitors are recommended in the treatment of all these diseases. The short case report demonstrates the case of a patient with acute coronary syndrome treated by percutaneous coronary intervention. After discharge from the hospital, consistent intervention of all cardiovascular risk factors is necessary, regular monitoring of blood pressure and lipid profile as well as anti-smoking intervention and monitoring of heart rate. Higher heart rate in hypertensive patients is considered to be another independent risk factor for cardiovacular diseases. During the treatment, according to the Guidelines of the European Society of Cardiology for the Prevention of Cardiovascular Diseases, fixed combinations should be preferred and used whenever a suitable combination in a fixed variant is available.
Keywords: sympathetic nervous system, renin-angiotensin-aldosterone system, fixed combination therapy.
Published: September 17, 2021 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018; 39(33): 3021-3104.
- 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2021; 42(14): 1289-1367.
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39(2): 119-177.
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020; 41(3): 407-477.
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37(27): 2129-2200.
Go to PubMed... - Myers MG. A dose-response study of perindopril in hypertension: effects on blood pressure 6 and 24 h after dosing. Perindopril Multicentre Dose-Response Study Group. Can J Cardiol. 1996; 12(11): 1191-1196
- Montvale NJ. Physicians-Desk reference, 55th ed. Medival Economist Company 2001.
- Bangalore S, Kumar S, Messerli FH. Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians' Desk Reference. Am J Med. 2010; 123(11): 1016-1030.
Go to original source... Go to PubMed... - Hiltunen TP, Suonsyrjä T, Hannila-Handelberg T, et at. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study). Am J Hypertens 2007; 20(3): 311-318. Go to original source... Go to PubMed...
- Chen X, Barywani SB, Hansson P-O, et al. Impact of changes in heart rate with age on all-cause death and cardiovascular events in 50-year-old men from the general population. Open Heart 2019; 6: e000856. doi: 10.1136/openhrt-2018-000856. Go to original source... Go to PubMed...
- Bangalore S, Kamalakkannan G, Parkar S, et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007; 120(8): 713-719. Go to original source... Go to PubMed...
- European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012; 33(13): 1635-1701.
- SPC přípravku Cosyrel. datum poslední revize textu 11. 6. 2021.